OnKure Therapeutics Financial Overview
OnKure Therapeutics's market cap is currently $39.83M. The company's EPS TTM is $-1.09; its P/E ratio is -0.50; OnKure Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-1.14. See an overview of income statement, balance sheet, and cash flow financials.
